Subsequently, specific knockout UPS22 in IECs increased the severity of inflammation in mice with DSS colitis and promoted colitis-related colorectal cancer, further confirming the role of USP22 in repressing intestinal inflammation and tumors (143). Here, USP22 is linked to colitis.